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Neuropsychiatric disorders are one of the leading causes of disability worldwide and affect
the health of billions of people. Previous publications have demonstrated that neuropsy-
chiatric disorders can cause histomorphological damage in particular regions of the brain.
By using a clinical symptom-comparing approach, 55 neuropsychiatric signs or symptoms
related usually to 14 types of acute and chronic brain insults were identified and catego-
rized in the present study. Forty percent of the 55 neuropsychiatric signs and symptoms
have been found to be commonly shared by the 14 brain insults. A meta-analysis sup-
ports existence of the same neuropsychiatric signs or symptoms in all brain insults. The
results suggest that neuronal damage might be occurring in the same or similar regions or
structures of the brain. Neuronal cell death, neural loss, and axonal degeneration in some
parts of the brain (the limbic system, basal ganglia system, brainstem, cerebellum, and
cerebral cortex) might be the histomorphological basis that is responsible for the neuropsy-
chiatric symptom clusters.These morphological alterations may be the result of secondary
neuronal damage (a cascade of progressive neural injury and neuronal cell death that is
triggered by the initial insult). Secondary neuronal damage causes neuronal cell death and
neural injury in not only the initial injured site but also remote brain regions. It may be a
major contributor to subsequent neuropsychiatric disorders following brain insults.
Keywords: neuropsychiatric disorders, secondary neuronal damage, brain insults, traumatic brain injury, neurode-
generative diseases, clinical manifestations, histomorphology, pathophysiology
Neuropsychiatric disorders, also called mental disorders or emo-
tional disorders, are conditions that affect cognition, emotion,
behavior, and substantially interfere with the ability to function
(1). Clinical manifestations of neuropsychiatric disorders include
memory and cognitive deficits, consciousness and sleep distur-
bances, mental and emotional symptoms, somatoform symptoms,
and psychomotor performance deficits. Neuropsychiatric disor-
ders are 4 of the 10 leading causes of disability worldwide (2).
About 26.2% of the U.S. adult population and 27% of the Euro-
pean Union adult population aged 18 and older, meet the diag-
nostic criteria for neuropsychiatric disorders at some point in
their lives (3, 4). Four hundred fifty million people worldwide
were diagnosed with some form of neuropsychiatric disorder
in 2001 (5).
The mechanism underlying neuropsychiatric disorders has not
been fully elucidated and still remains controversial. Several differ-
ent factors may be involved in the occurrence and development of
neuropsychiatric disorders. Psychological (violent attacks, being
abused or neglected, marital separation, divorce, the sudden death
of a loved one, being unable to relate to others, etc.), biological
(genetics, prenatal damage, infections, exposure to toxins, brain
defects or injuries, chemical imbalances, and substance abuse),
and social/environmental (such as poor social and work relation-
ships, family argument, dispute at work, loss of job, retirement,
unemployment or underemployment, serious financial problems,
poverty, socioeconomic deprivation, and substance abuse) factors
are usually considered to be the triggers that cause most neu-
ropsychiatric disorders (6–11). Research thus far does not clearly
demonstrate how these triggers can cause neuropsychiatric dis-
orders in the brain, nor what the cellular and molecular changes
associated with the mental diseases are. The histomorphological
basis of a neuropsychiatric disorder has been generally ignored.
Every disease has its own histomorphological features. A dis-
ease will not occur without morphological alterations associated
with the disease in cells, tissues, and organs. When the cause and
pathomorphology of a disease are poorly understood, people usu-
ally mythologize the disease and attribute the symptoms to social
and cultural problems such as a sedentary lifestyle, social iso-
lation, depressed mood, economic crisis, overindulgence in sex,
obesity, heredity, etc. For example, tuberculosis had been consid-
ered as a fatal wasting disease (consumption) caused by vampires
before Mycobacterium tuberculosis was discovered in 1882 (12).
Therefore, definition of morphological alterations at the cellular
and molecular levels is a very important step in the diagnosis and
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Table 1 |The initial causes of brain insults.
Brain insult Cause of injury
Stroke Progressive neuron death caused by disturbance in the blood supply to the brain (ischemia or hemorrhage)
Brain tumor A tumor (an abnormal growth of cells) within the brain
TRAUMATIC BRAIN INJURY (TBI)
Blast-induced TBI Progressive neuron death caused by blast shock waves
Closed head injury Progressive neuron death caused by external physical force(s)
NEURODEGENERATIVE DISEASES
Parkinson’s Greatly decreased activity of dopamine-secreting cells caused by progressive neuron death in the basal ganglia
Alzheimer’s Progressive neuron death and synapses loss in the cerebral cortex, limbic system, and the brainstem
Amyotrophic lateral sclerosis Progressive death of motor neurons in the cortex and the brainstem, characterized by proteinaceous inclusions
in neuron bodies and axons
Huntington’s (Chorea) An autosomal dominant mutation in Huntington gene on chromosome 4 causes cellular accumulation of protein
clumps, inducing cellular toxicity, and progressive neuron death primarily in the basal ganglia and the cortex
POISONING WITH HAZARDOUS CHEMICALS
Organophosphate pesticides/chemical
nerve agents
Cholinergic neuronal deficits induced by irreversible AChE inhibition
Chemical neurotoxic substances Progressive neuron death caused by neurotoxicity-induced ionic imbalance in neurons
Alcohol abuse Progressive neuronal damage resulting from the combination of prolonged ingestion of alcohol, which may
involve abnormal release of neurotransmitters and prolonged stimulation of reward circuitry
Drug abuse The release and prolonged action of dopamine and 5-HT within the reward circuit of the brain activate the
reward system and lead to drug addiction, which cause chronic neuropathy in the brain
INFECTIONS BY PATHOGENIC MICROBES
HIV/AIDS Progressive neuron death caused by the harmful inflammatory cascades including activation of macrophages
and microglia, release of inflammatory mediators, and induction of uncontrolled inflammation
PANDAS An autoimmune-mediated response to a streptococcal infection, which produces antineuronal antibodies to
erroneously destroy normal neurons in the basal ganglia
treatment of the disorder in general. A recent study has suggested
that neuropsychiatric disorders triggered by psychological and
social/environmental factors may involve a volumetric blood surge
created by a sudden rise in cardiovascular pressure after exposure
to an emotionally and psychologically traumatic event. The vol-
umetric blood surge will move quickly through blood vessels to
the brain, dramatically increasing cerebral perfusion pressure and
causing damage to both very small cerebral blood vessels in the
brain and to the blood brain barrier (BBB) (13). This indicates
that brain microstructural damage could be the histomorpholog-
ical basis of neuropsychiatric disorders triggered by psychological
and social/environmental factors.
In the present study, a clinical symptom-comparing approach
was employed to identify the similarities and differences among
the neuropsychiatric manifestations related to 14 different types
of brain insult. To explore the potential mechanisms that cause
neuropsychiatric disorders, the correlation between neuropsy-
chiatric manifestations and pathomorphology of the brain was
analyzed.
BRAIN INSULTS SELECTED FOR STUDY
Neuropsychiatric disorders frequently occur after various brain
insults such as closed head injury (CHI) (caused by external
physical forces), blast-induced traumatic brain injury (TBI)
(caused by blast shock waves), stroke (including ischemic and
hemorrhagic stroke), poisoning with hazardous chemicals [caused
by organophosphate (OP) pesticides, chemical nerve agents,
chemical neurotoxic substances, alcohol, drugs, etc.), infection by
pathogenic microbes (such as HIV/AIDS and PANDAS), brain
tumors (including gliomas, meningiomas, pituitary adenomas,
and nerve sheath tumors), and degenerative diseases [such as
Parkinson’s, Alzheimer’s, amyotrophic lateral sclerosis (ALS), and
Huntington’s]. Although these brain insults can induce many of
the same neuropsychiatric disorders, their initial causes of injury
are totally different (Table 1).
ACUTE BRAIN INSULTS
Closed head injury
Closed head injury is a type of TBI caused primarily by motor
vehicle accidents, sporting activities, accidental falls, assaults, etc.,
where the skull and dura mater remain intact. CHI can range
from mild to severe. CHI causes initial damage only to spe-
cific brain parts, the impact site or opposite side of the skull.
Post-injury pathophysiological changes are usually observed in
areas bordering the injured sites, and not in the entire brain
(14, 15).
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Blast-induced TBI
Blast-induced TBI is a unique type of brain injury that is caused
by blast shock waves in the victims who are exposed to a blast
but do not sustain penetrating and blunt impact injuries. The vast
majority (~90%) of blast-induced TBI cases are mild. The major
mechanism of blast TBI may involve large-scale BBB damage and
tiny cerebrovascular insults in the entire brain, which are caused
by the blood surge moving quickly through large blood vessels to
the brain from the torso (16).
Stroke
Stroke is a brain damage characterized by the sudden disruption
of blood supply to an area of the brain and the rapid loss of brain
function. It is the second leading cause of death worldwide. Stroke
can be caused by an obstruction in the blood flow (ischemic stroke)
or the rupture of a blood vessel that supplies the brain (hemor-
rhagic stroke). A loss of blood supply to part of the brain will
initiate a pathophysiological cascade that leads to irreversible death
of neuronal cells and permanent neurological dysfunction. The
symptoms depend on the area of the brain affected, but generally
symptoms include sudden loss of the ability to speak, memory and
cognitive deficits, visual field defect, and hemiplegia (17, 18).
Organophosphate pesticides/chemical nerve agents
Organophosphate compounds are a group of highly toxic chem-
icals that have been used widely as pesticides and developed as
chemical warfare nerve agents such as soman (GD), sarin (GB),
tabun (GA), cyclosarin (GF) and VX. OP pesticides/chemical
nerve agents disrupt the functioning of cholinergic nervous sys-
tem by irreversibly inhibiting acetylcholinesterase (AChE). The
inhibition of AChE by OPs results in both the accumulation of
ACh at synapses of the central and peripheral nervous systems
and overstimulation of cholinergic receptors that exceeds normal
physiological limits. Acute, excessive stimulation of cholinergic
receptors (mAChR, in the brain) causes cholinergic neuronal exci-
totoxicity and dysfunction, which are largely responsible for the
cholinergic crisis in the acute phase of the OP exposures, and could
subsequently cause brain damage and chronic neuropsychiatric
consequences (19).
Chemical neurotoxic substances
Chemical poisoning is a condition in which a harmful chemical
causes damage to human cells, tissues, or organs, usually by chemi-
cal reaction or other activity at the molecular level after a sufficient
amount is absorbed by the human body. Chemical poisoning is a
major public health concern and the second leading cause of injury
and death worldwide (20, 21). Chemical poisoning can be caused
by approximately 3,000 hazardous chemicals.
Chemical neurotoxic substances (such as acetone, benzene,
lead, mercury, and strychnine) cause damage to the brain by dis-
rupting ionic balance in neuronal cells, interrupting neural signal
transmission between neurons, altering normal brain function,
and inducing progressive neuronal cell death and neurodegener-
ation. Clinical manifestations may vary among the victims who
are exposed to chemical neurotoxic substances, depending on the
specific compound, the amount, the route, and the length of time
of exposure, as well as on the age and health status of the person
exposed (22, 23).
HIV/AIDS
The brain can be infected by pathogenic microbes such as bacteria
and viruses. Infections by pathogenic microbes can cause harmful
inflammatory cascades in the brain, because cerebral cellular infil-
tration in response to microbial invasion is weaker, and delayed
and inflammatory response in the brain is much stronger and
spreads more rapidly than in other organs or tissues (24). There-
fore, an overactive immune response to microbial invasion in the
brain should be the major contributor to infection-related brain
damage.
HIV/AIDS is a disease of the human immune system caused
by infection with HIV. Although the immune system is the prin-
cipal target of HIV, the brain can be also affected by HIV. HIV-
associated psychiatric disorders have been observed in more than
50% of patients with HIV/AIDS (25). These neuropsychiatric dis-
orders may be caused by progressive neuronal cell death resulting
from the harmful inflammatory cascades, including activation of
macrophages and microglia to release inflammatory mediators
such as cytokines, eicosanoids, and complements, and overstimu-
lation of the immune system to lead to uncontrolled inflammation
in the brain (26, 27).
Pediatric autoimmune neuropsychiatric disorders associated with
streptococcal infections
Pediatric autoimmune neuropsychiatric disorders associated with
streptococcal infections (PANDAS) are neuropsychiatric disorders
[usually obsessive–compulsive disorder (OCD) and/or tic disor-
ders] following a Group A beta-hemolytic streptococcal infection
(GABHS) in children (28, 29). The mechanism behind PANDAS
may involve an autoimmune-mediated response to a streptococcal
infection, which produces antineuronal antibodies to erroneously
destroy normal neuronal cells in the basal ganglia (30).
CHRONIC BRAIN INSULTS
Brain tumor
Brain tumor is an intracranial solid neoplasm that is formed by an
accumulation of abnormal growth cells. The most common types
are glioma and astrocytic tumors from abnormal growth glial and
astrocytes cells. The second most common type of brain tumor is
meningeal tumor that forms in the meninges. Pituitary adenomas
are the third most common type of brain tumor; these are non-
cancerous tumors of the pituitary gland. Nerve sheath tumors are
made up primarily of the myelin surrounding nerves and account
for approximately 8% of all brain tumors. The symptoms of brain
tumors mainly depend on tumor size and tumor location, but
common clinical consequences include symptoms of intracranial
hypertension, neurological and neuropsychiatric disorders, and
psychomotor performance deficits (31–34).
Alcohol abuse
Alcohol abuse is an addictive illness that is caused by uncontrolled
consumption of alcoholic beverages. Prolonged ingestion of alco-
hol will affect brain function by altering levels of neurotransmitters
(GABA, glutamate, and dopamine) and inducing prolonged stim-
ulation of reward circuitry, thus causing progressive brain damage.
The brain areas that are commonly affected by alcohol are the cere-
bral cortex, cerebellum, hypothalamus and pituitary, and medulla.
www.frontiersin.org March 2014 | Volume 5 | Article 22 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chen et al. Brain insults and neuropsychiatric disorders
In cerebral cortex, alcohol depresses the behavioral inhibitory cen-
ters, inhibits the thought processes, and slows down the processing
of information from the eyes, ears, mouth, and other senses. This
will cause the slowed reaction times, impaired memory, blurred
vision, slurred speech, etc. If alcohol affects the cerebellum (the
center of movement and balance), it leads to the “staggering gait
of a drunk” or difficulty walking. Alcohol depresses the hypothal-
amus and pituitary to increase sexual urge, but decrease actual
sexual performance. The hypothalamus and pituitary control sex-
ual arousal and performance by coordinating automatic brain
functions and hormone release. By acting on the medulla, alcohol
induces sleepiness and deficits of consciousness, slows breathing,
and decreases body temperature, which may cause death (35, 36).
Drug abuse
Drug abuse, also known as substance abuse, is a disorder that is
caused by using an illicit drug to feel happy and excited, to be more
productive or to help one stay awake, to improve athletic perfor-
mance, or to ease another mental and emotional problem (such
as stress, anxiety, or depression) (37, 38). Drug abuse has led to
significant physical, psychological, and public health problems in
almost every country. About 200 million people around the world
use illegal drugs every year. More than 22 million Americans aged
12 and older (nearly 9% of the U.S. population) used illegal drugs
in 2011 (39). The mechanism by which illicit drugs cause brain
damage remains unknown. Some drugs may cause the neuronal
cells to release abnormally large amounts of dopamine and 5-HT
and produce prolonged enhancement of synaptic transmission
within the reward circuit of the brain, thus causing progressive
brain damage (40, 41).
MDMA (or called ecstasy) is an empathogenic drug of the
phenethylamine and amphetamine classes of drugs. The effects
of MDMA on human brain are complex. MDMA may cause
the neuronal cells to release 5-HT, dopamine, and norepineph-
rine, and may act directly on a number of receptors, including
α2-adrenergic and 5-HT2A receptors (42). MDMA can result in
serotonergic neurotoxicity and psychiatric and behavioral prob-
lems such as memory loss, cognitive deficit, moodiness, aggression,
anxiety, sleep disorder, hypersexuality, and increased sensitivity
to pain (43). Cocaine is a crystalline tropane alkaloid obtained
from the coca plant, and a CNS stimulant. It acts as both a
serotonin–norepinephrine–dopamine reuptake inhibitor and a
triple reuptake inhibitor, and affects the mesolimbic reward path-
way to cause addiction (44). Cocaine blocks the reuptake of
serotonin, norepinephrine, and dopamine by the neurons that
release it, allowing higher concentrations of the neurotransmit-
ters to remain in the synapse for an extended period of time. This
abnormally long presence and high concentration of neurotrans-
mitters in the synapse will lead to brain dysfunction and damage
in the particular parts of the brain such as the basal ganglia and the
limbic system, thus causing psychiatric and behavioral problems
including memory and cognitive deficits, dysphoria, depression,
insomnia or hypersomnia, psychomotor retardation or agitation,
elevated mood, supremacy feeling, irritability, paranoia, restless-
ness, anxiety, dilated pupils, excited and exuberant speech, etc.
(45–47). Methamphetamine is a neurotoxin and potent psychos-
timulant of the phenethylamine and amphetamine classes. It is
directly neurotoxic to both dopamine and serotonin neurons and
can cause brain damage from long-term use in humans (48). This
brain damage leads to adverse changes in brain structure and func-
tion such as reductions in gray matter volume in several brain
regions and adverse changes in markers of metabolic integrity. The
neuropsychiatric effects of methamphetamine include euphoria,
dysphoria, anxiety, depression, elevated mood, changes in libido,
alertness, apprehension, impaired concentration, decreased sense
of fatigue, insomnia, self-confidence, sociability, irritability, rest-
lessness, psychosis, suicide, violent behaviors, and repetitive and
obsessive behaviors (49). Marijuana, also known as Cannabis, is a
psychoactive drug that is often consumed for heightened mood,
euphoria, and relaxation. Marijuana has a role in the brain’s con-
trol of memory, cognition, and movement. It interacts with the
brain’s endogenous opioid system and affects dopamine transmis-
sion (50). Marijuana use is associated with psychiatric and behav-
ioral problems (such as memory and cognitive deficits, anxiety,
depression, paranoia, auditory and visual hallucination, reddening
of the eyes, impaired motor skills), and increases a risk for mental
disorders (such as schizophrenia, depersonalization disorder, and
bipolar disorders) (51).
Parkinson’s disease
Neurodegenerative diseases are characterized by the progressive
neuron death/loss and synapses loss in some brain regions such as
the cortex, brainstem, and basal ganglia, resulting in the progres-
sive deterioration of neurological and neuropsychiatric symptoms,
permanent disability, and death. Parkinson’s disease is the result
of death and loss of dopamine-secreting cells in the basal gan-
glia. Progressive dopamine-secreting cell death causes a marked
decrease in dopamine levels of the brain that induces obvious
motor symptoms including shaking, rigidity, slowness of move-
ment, and difficulty with walking and gait at the early stage of the
disease. Later in the course of the disease, neuropsychiatric symp-
toms such as depression, memory and cognitive deficits, emo-
tional symptoms, and other behavioral problems are commonly
observed in most patients (52–55).
Alzheimer’s disease
Alzheimer’s disease is an irreversible, progressive neurologic dis-
ease of the brain that slowly causes memory loss, cognitive
impairments, and other mental illnesses (53). It is character-
ized by progressive neuron death and loss of synapses in the
cerebral cortex, limbic system, and the brainstem (56, 57). An
abundance of amyloid plaques and neurofibrillary tangles in the
areas of the brain affected is a typical feature of Alzheimer’s
disease (58).
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a degenerative motor neuron dis-
ease characterized by the gradual degeneration and death of motor
neurons in the cortex and the brainstem. ALS causes rapidly pro-
gressive weakness, muscle atrophy, fasciculations and spasticity,
dysarthria, dysphagia, and dyspnea. Some patients with ALS have
cognitive and memory deficits, depression, and other mental and
emotional disorders (59, 60).
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Huntington’s disease
Huntington’s disease (HD), also called Huntington’s chorea, is
an inherited neurodegenerative disorder that is caused by an
autosomal dominant mutation in Huntington gene on chromo-
some 4. The Huntington gene mutation causes cellular accumula-
tion of protein clumps, inducing cellular toxicity and progressive
cell death primarily in the basal ganglia and the cortex (61–63). HD
affects the individual’s muscle coordination, judgment, memory,
and other cognitive function, thus leading to uncontrolled move-
ments, cognitive and memory deficits, and other neuropsychiatric
disorders (64–66).
COMPARISON OF NEUROPSYCHIATRIC MANIFESTATIONS OF
BRAIN INSULTS
Clinical manifestations of neuropsychiatric disorders include both
signs and symptoms. The neuropsychiatric signs and symptoms
indicate the presence of disease or abnormality in the brain. Some
signs and symptoms (such as fatigue, nausea, vomiting, and hyper-
sexuality) may be non-specific and can occur in many acute and
chronic medical conditions, whereas most signs and symptoms
are fairly specific for a brain disease or injury (such as memory
loss, cognitive impairments, consciousness loss, anxiety, depres-
sion, and psychosis). The specific signs and symptoms should
be meaningful and significant in assisting the diagnosis of brain
insult(s).
The clinical symptom-comparing approach that was employed
in the present study is a clinical research method to determine the
same signs and symptoms that are commonly shared by two or
more brain insults. Through literature search and review, the signs
and symptoms relating to these brain insults are identified and
categorized into different categories. All signs or symptoms iden-
tified are compared among different types of brain insults using
Microsoft Excel. The same sign or symptom will be identified if
this sign or symptom is commonly presented in all types of brain
insults. A meta-analysis will be used to determinate whether the
same signs or symptoms exist in these brain insults and what the
effect size of the same signs or symptoms is.
LITERATURE SEARCH ON NEUROPSYCHIATRIC SIGN/SYMPTOM
CLUSTERS OF BRAIN INSULTS
Articles relating to the neuropsychiatric signs and symptoms of the
14 types of acute and chronic brain insults were searched between
the years 1970 and 2013 using NIH PubMed database for keywords
such as “Stroke,” “Patient,” and “Memory loss.” A neuropsychi-
atric sign or symptom that was reported or described in at least
three different articles was selected as a common sign or symp-
tom for the brain insult. Fifty-five common signs or symptoms
were identified for the 14 types of brain insult (Supplementary
Table 1). They are categorized into five major categories: mem-
ory and cognitive deficits (memory loss, concentration difficulties,
cognitive impairments, learning disabilities, etc.); consciousness
and sleep disturbances (sleep disorder, insomnia, consciousness
loss, etc.); mental and emotional symptoms (anxiety, depression,
aggression, moodiness, etc.); somatoform symptoms (headache,
reduced visuo-spatial abilities, blurred vision, fatigue, etc.); and
impaired psychomotor and neuromotor functions (psychomotor
retardation, lack of motor coordination, difficulty balancing,
seizures/tremors, etc.) (Table 2).
IDENTIFICATION OF NEUROPSYCHIATRIC SIGNS/SYMPTOMS
COMMONLY SHARED BY ALL OF THE 14 BRAIN INSULTS
Based on the 528 supplementary references in the Supplementary
Material, 40% (22) of the 55 neuropsychiatric signs and symp-
toms were found to be commonly shared by all of the 14 brain
insults, whether traumatic, infectious, toxic, oncogenic, or degen-
erative (Table 2). In the category “memory and cognitive deficits,”
six symptoms (memory loss, concentration difficulties, cogni-
tive impairments, learning disabilities, forgetfulness, and impaired
attention) are shared; in the category “consciousness and sleep
disturbances,” two symptoms (sleep disorder and insomnia) are
shared; in the category “mental and emotional symptoms,” six
symptoms (anxiety, depression, aggression/agitation, psychosis,
moodiness, and increased emotional sensitivity) are shared; in
the category “somatoform symptoms,” four symptoms (headache,
reduced visuo-spatial abilities, blurred vision/visual field impair-
ment, and fatigue) are shared; and in the category “impaired
psychomotor and neuromotor functions,” four symptoms
(psychomotor retardation, lack of motor coordination, difficulty
balancing, and seizures/tremors) are shared. Overlap of neu-
ropsychiatric symptom clusters among different brain insults
is shown in Figure 1. The 22 of the same neuropsychiatric
manifestations were simultaneously identified in either acute
(Figures 1A,B) or chronic (Figures 1C,D) brain insults. Many
overlapping neuropsychiatric signs or symptoms were also found
between each of the brain insults. This suggests that neuronal
damage may be caused by these brain insults in the same or sim-
ilar brain regions/structures or that the same or similar brain
regions/structures can be possibly affected by different brain
insults.
A meta-analysis was conducted to combine clinical manifesta-
tions of different brain insults and to determinate the neuropsychi-
atric signs or symptoms commonly shared by all acute and chronic
brain insults. The meta-analytic procedure adopted for this sys-
tematic study was based upon the methods described by Neyeloff
et al. (67). The total numbers of patients presenting with all of the
same neuropsychiatric signs or symptoms were used as the sample
size for each brain insult. A matrix of sample-size weighted simi-
larity coefficients between each of the 14 types of brain insults was
computed in the meta-analysis. Forest plots of the meta-analysis
give the effect estimate (the rate) and its 95% confidence interval
for each insult. The overall combined effect size is indicated by
a diamond. The meta-analysis of neuropsychiatric manifestations
of the patients with brain insults shows that the same neuropsy-
chiatric signs or symptoms exist in the 14 different types of brain
insults (Figure 2).
IDENTIFICATION OF NEUROPSYCHIATRIC SIGNS/SYMPTOMS
COMMONLY SHARED BY MORE THAN 10 DIFFERENT TYPES OF BRAIN
INSULT
Other neuropsychiatric signs or symptoms were found to be
commonly shared by more than 10 different types of brain
insult: 6 neuropsychiatric signs or symptoms (impaired judg-
ment, confusion, disorientation, fear/frightened, behavior stress,
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FIGURE 1 | Overlap of neuropsychiatric symptom clusters among
different types of brain insults. (A) Overlap of symptom clusters among
closed head injury, blast-induced TBI, and stroke; (B) Overlap of symptom
clusters among OP/chemical nerve agents, chemical neurotoxic
substances, HIV/AIDS, and PANDAS; (C) Overlap of symptom clusters
among brain tumor, alcohol abuse, and drug abuse; and (D) Overlap of
symptom clusters among Parkinson’s disease, Alzheimer’s disease, ALS
and Huntington’s disease.
and altered hearing and ringing in the ears) are shared by 13
brain insults; 2 neuropsychiatric signs or symptoms (demen-
tia, and unusual temper tantrums/irritability) are shared by 12
brain insults; 4 neuropsychiatric signs or symptoms (mania, sui-
cidal thoughts/attempts, nausea, and vomiting) are shared by 11
brain insults; and 5 neuropsychiatric signs or symptoms (con-
sciousness loss, restlessness, hallucinations, dizziness, and apha-
sia) are shared by 10 brain insults (Supplementary Table 1).
Interestingly, the symptom of suicidal thoughts or attempts was
commonly found in the cases of 11 different types of brain
insult (CHI, blast-induced TBI, stroke, poisoning due to chem-
ical neurotoxic substances, HIV/AIDS, alcohol abuse, drug abuse,
Parkinson’s disease, Alzheimer’s disease, ALS, and HD). This
suggests that suicidal thoughts or attempts may be a result
of brain damage. A patient who has attempted suicide may
be suffering from degeneration or death of neuronal cells in
the brain, and need medical interventions for potential brain
damage.
Post-traumatic stress disorder (PTSD) was found to be com-
monly shared by nine different brain insults (CHI, blast-induced
TBI, stroke, poisoning with OP pesticides/chemical nerve agents,
poisoning due to chemical neurotoxic substances, HIV/AIDS,
brain tumor, alcohol abuse, and drug abuse). PTSD is char-
acterized by persistent re-experiencing symptoms, avoidance
symptoms, and hyperarousal symptoms. It is closely associated
with some brain insults such as TBI, stroke, brain tumor,
and OP poisoning. PTSD symptoms developed in 50–80% of
mild TBI patients (16), 25–50% of stroke survivors (68), 35%
of childhood brain tumor survivors (69), and 8–23% of the
victims of OP poisoning (70). PTSD is most likely to be a
special delayed-onset neuropsychiatric disorder caused directly
by brain injury or disease, not caused by exposure to trau-
matic stress.
CORRELATION BETWEEN CLINICAL MANIFESTATIONS AND
HISTOMORPHOLOGICAL ALTERATIONS OF THE BRAIN
A neuropsychiatric disorder should have its morphological alter-
ations in the brain. Any brain insult can certainly cause histo-
morphological, biochemical, or molecular biological alterations
in some parts of the brain, such as the limbic system, basal ganglia
system, the brainstem, the basal forebrain, the cerebellum, and the
cerebral cortex. Unfortunately, these alterations at the cellular and
molecular level are usually not easy to detect by using traditional
diagnostic imaging techniques (e.g., ultrasound, X-rays, CT, and
MRI), because tiny morphological changes (such as neuronal cell
death or loss) in deep brain structures (such as the limbic system
and basal ganglia system) can be often covered by other normal
neural tissue layers of the brain. Much of the neuronal damage in
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FIGURE 2 | Meta-analysis of the same neuropsychiatric signs and
symptoms shared by all acute and chronic brain insults. Forest
plots of the meta-analysis show effect size (the rate) and 95%
confidence intervals for randomized. The overall combined effect size
is indicated by a diamond. Heterogeneity I2 =0% for all brain insults
combined.
deep brain structures can be seen only under a microscope after
death (13).
MORPHOLOGICAL ALTERATIONS OF NEUROPSYCHIATRIC DISORDERS
Recently, morphological alterations of some neuropsychiatric dis-
orders (such as schizophrenia, depression, bipolar disorder, and
drug abuse) have been verified in patients and animal models by
using structural and functional brain imaging technologies and
histopathological examinations. Reductions in brain volume have
been reported in areas of the frontal cortex, temporal lobes, and
brain stem in patients with Schizophrenia (71–74). Morphological
abnormalities in frontal–striatal–temporal areas (75), hippocam-
pus (76), and the brain stem (72) have been observed in patients
with depression and in a female monkey model of depression.
Meta-analyses of structural MRI studies in bipolar disorder show
that there is an increase in both the volume of the lateral ventricles
and globus pallidus, and the rates of deep white matter hyperin-
tensities (77, 78). Functional MRI findings suggest that abnormal
modulation between ventral prefrontal and limbic regions, espe-
cially the amygdala, likely contribute to poor emotional regulation
and mood symptoms in the bipolar disorder patients (79). Mor-
phological abnormalities in the brain stem have been founded
in post-mortem tissue of bipolar disorder patients (72). In drug
abusers, neuronal loss, neurodegenerative alterations, a reduction
of glial fibrillary acidic protein-immunopositive astrocytes, and
widespread axonal damage with concomitant microglial activa-
tion as well as reactive and degenerative changes of the cerebral
microvasculature have been observed (80, 81). These evidences
demonstrate that neuropsychiatric disorders can cause histomor-
phological damage in particular regions of the brain. Histomor-
phological damage in the brain will induce individual symptoms
or clusters of neuropsychiatric disorders. The location, extent, and
degree of brain tissue damage may correlate closely with the type
and severity of neuropsychiatric symptoms.
BRAIN REGIONS/STRUCTURES INVOLVED IN BOTH THE CATEGORY
“MEMORY AND COGNITIVE DEFICITS” AND THE CATEGORY “MENTAL
AND EMOTIONAL SYMPTOMS”
Both “memory and cognitive deficits” and “mental and emotional
symptoms” may involve neuronal damage in several parts of the
brain including the limbic system (the hippocampus, the amyg-
dala, the cingulate gyrus, the thalamus, the hypothalamus, the
epithalamus, the mammillary body), basal ganglia system (the
striatum), the cerebellum, and the cerebral cortex (frontal lobe
and temporal lobe) (82, 83). The limbic system is a complex
set of brain structures that lie on both sides of the thalamus,
right under the cerebrum. It plays a key role in learning, cogni-
tion, long-term memory, emotion, motivation, social processing,
and behavior. It also influences the endocrine system and the
autonomic nervous system. Damage to the limbic system causes
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many neuropsychiatric disorders including anxiety disorder, bipo-
lar (affective) disorder,psychopathic disorders, amnestic disorders,
schizophrenia, and dementias (84, 85). The basal ganglia system
is a group of nuclei located near the thalamus and hypothala-
mus. It consists of the striatum, the globus pallidus, the substantia
nigra, the nucleus accumbens, and the subthalamic nucleus (86).
It is strongly connected with the cerebral cortex, thalamus, and
other brain areas to act as a cohesive functional unit by receiv-
ing input from the cerebral cortex and by sending outputs to
the motor centers in the brain stem. The basal ganglia system
is associated with a variety of functions, including reward learn-
ing involving dopamine release and transmission, cognitive and
emotional functions, posture and movement, eye movements, and
executive functions. Basal ganglia dysfunction has been implicated
in a number of neuropsychiatric disorders such as Parkinson’s
disease, HD, schizophrenia, Tourette syndrome, hemiballismus,
and obsessive–compulsive disorder (87, 88). The cerebellum is a
region that is located at the bottom of the brain underneath the
cerebral hemispheres. It plays an important role in motor coordi-
nation, balance, posture, sensory perception, cognitive functions
such as attention and language, and regulation of fear and pleasure
responses (89). Cerebellar damage produces disorders related to
fine movement and motor coordination (90). The cerebral cortex
is the outermost layered structure covering the brain. It is often
referred to as gray matter because it consists of cell bodies and
capillaries. The cerebral cortex is the largest part of the human
brain, associated with higher cortical functions such as cogni-
tion, memory, learning, attention, thought, language, information
processing, abstraction, creativity, judgment, emotion, conscious-
ness, voluntary muscle activity, somatic sensation, visual stimuli,
and movement planning. Almost all neuropsychiatric disorders
involve different degrees of damage that occur in the cerebral
cortex (91, 92).
BRAIN REGIONS/STRUCTURES INVOLVED IN THE CATEGORY
“CONSCIOUSNESS AND SLEEP DISTURBANCES”
Consciousness and sleep disturbances may be the result of neu-
ronal damage in the brainstem reticular formation,basal forebrain,
the limbic system (hypothalamus and thalamus), and the cere-
bral cortex (frontal lobe). The reticular formation is a region in
the brainstem that has projections to the thalamus and cerebral
cortex. It plays a central role in states of consciousness like alert-
ness and sleep by regulating the sleep–wake cycle and filtering
incoming stimuli to discriminate irrelevant background stimuli
(93, 94). Injury to the brainstem reticular formation can result in
coma, consciousness loss, and insomnia (95, 96). The basal fore-
brain is a group of structures located rostrally and ventrally to
the striatum. It is considered to be the major cholinergic out-
put of the brain, and can regulate wakefulness and REM sleep
by the induction of ACh release. Damage to the basal forebrain
can reduce the amount of acetylcholine in the brain and lead to
impaired learning, amnesia, sleep disorder, and lethargy (97, 98).
Other brain structures such as the hypothalamus and thalamus
of the limbic system and frontal lobe of the cerebral cortex may
also involve coordinated regulation of sleep–wake function and
conscious states with the reticular formation and basal forebrain
(99, 100).
BRAIN REGIONS/STRUCTURES INVOLVED IN THE CATEGORY
“SOMATOFORM DISORDERS”
Somatoform disorders are a group of neuropsychiatric disorders
characterized by physical symptoms that suggest physical illness
or injury. However, the cause for the symptoms cannot be fully
explained by a general physical illness because physical exami-
nations and clinical lab tests do not indicate the presence of a
physical illness (101). This has led to the hypothesis that the
physical symptoms of these patients’ experience may be from
a neuropsychiatric source associated with brain damage (102).
Somatoform symptoms should not be the result of conscious
malingering or factitious behavior. They may be relevant to the
damage to some parts of the cerebral cortex (such as dorsolateral
prefrontal, insular, rostral anterior cingulate, premotor, parietal
cortices, and parahippocampal gyrus) (103, 104). Because the
cerebral cortex controls sensory–motor coupling, sensory feed-
back system, and somatic sensation, cortical damage may cause
increased sensitivity to internal physical sensations and pain. The
increased sensitivity to somatic feelings may predispose patients
to produce somatoform symptoms (105, 106).
BRAIN REGIONS/STRUCTURES INVOLVED IN THE CATEGORY
“IMPAIRED PSYCHOMOTOR AND NEUROMOTOR FUNCTIONS”
Impaired psychomotor and neuromotor functions are defined as
abnormalities of motor function that are associated with neu-
ropsychiatric and neurological disorders. Psychomotor impair-
ment (also known as psychomotor retardation) involves a visible
slowing of movement (difficulty completing simple tasks such
as showering, getting out of bed, or lifting relatively lightweight
objects), a general reduction in the speed of thought (such as
unable to perform basic math calculation, to find directions on a
map, or to plan daily schedule), and difficulty in speaking (such as
aphasia) (107, 108). Psychomotor impairment is most-commonly
observed in patients with depression and bipolar disorder (109).
Neuromotor impairment is a disorder caused by histomorpho-
logical, biochemical, or molecular biological abnormalities in the
brain. Brain damage is the major contributor to the abnormalities,
which can result in a range of neuromotor dysfunction symptoms
including poor motor coordination, involuntary movements, dif-
ficulty with balance, gait, and mobility control problems, seizures,
tremors, spasms, muscle weakness and atrophy, reduced muscle
tone, and paralysis (110, 111). Impaired psychomotor and neuro-
motor functions may result from neuronal damage in the cerebral
cortex (the posterior parietal, the primary motor, the premo-
tor, and the supplementary motor cortices), the cerebellum, and
the basal ganglia system (112–114), because the three regions of
the brain are involved in motor coordination, balance, voluntary
muscle activity, movement planning, posture and movement, and
sensory perception.
POTENTIAL MECHANISMS INVOLVED IN
NEUROPSYCHIATRIC DISORDERS FOLLOWING BRAIN
INSULTS
SECONDARY NEURONAL DAMAGE
Unlike other tissues or organs, the brain is a very soft, tofu-like
tissue. Although it is protected by the skull and cerebrospinal fluid
and isolated from large or hydrophilic molecules (bacteria and
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high-molecular-weight toxins) in the blood stream by the BBB,
the brain is extremely susceptible to injury and disease (115). An
insult (injury or disease) to the brain may cause more serious
consequences than to other tissues. Much of the damage done
to the brain does not typically occur at the time of initial insult
and does not result directly from the initial insult itself. The pro-
gressive deterioration in the brain functions following the initial
brain insult results mainly from secondary neuronal damage, a
cascade of progressive neural injury and neuronal cell death that
is triggered by the initial insult. Secondary neuronal damage usu-
ally occurs in both the initial injured site and other brain regions
remote from the initial injured site (such as the hippocampus,
amygdale, thalamus, the brainstem, basal ganglia system, the cere-
bellum, and piriform cortex), and possibly continues in the hours,
days, weeks, or months following the initial insult. It is largely
responsible for the ultimate neuronal cell death and neural loss
in the injured brain, and is a major contributor to subsequent
neuropsychiatric impairments (19).
Secondary neuronal damage can be induced by the patho-
physiological changes associated with the initial insults such as
cerebral edema, inflammation, cytotoxicity, cerebral ischemia,
reduced cerebral blood flow, cerebral hypoxia, hypercapnia, aci-
dosis, altered neurotransmitter release, and raised intracranial
pressure. Acute brain insults (such as TBI, stroke, poisoning
with OP pesticides, chemical nerve agents or chemical neuro-
toxic substances, and infections by pathogenic microbes) can
cause almost all pathophysiological changes as mentioned above.
However, chronic brain insults (such as brain tumors, alcohol
abuse, drug abuse, and neurodegenerative diseases) may induce
only some of these pathophysiological changes. For example, a
brain tumor leads to raised intracranial pressure, cerebral edema,
inflammation, cerebral hypoxia, cytotoxicity, and altered neuro-
transmitter release. Neurodegenerative diseases, alcohol abuse,
and drug abuse induce altered neurotransmitter release, cytotox-
icity, cerebral edema, and inflammation. This may suggest that
secondary neuronal damage can occur from the pathophysiologi-
cal changes following various acute or chronic brain insults. The
involvement of secondary neuronal damage will exacerbate neu-
ronal injury and neurologic deficits, ultimately causing irreversible
neuropsychiatric and neurological impairments (Figure 3).
PATHOPHYSIOLOGICAL CHANGES ASSOCIATED WITH SECONDARY
NEURONAL DAMAGE
Cerebral edema, inflammation, cytotoxicity, loss of cerebral blood
flow autoregulation, and the apoptosis program are thought to be
the major contributors to secondary neuronal damage.
Cerebral edema
Cerebral edema is a condition characterized by an excess accu-
mulation of water in the intracellular or extracellular spaces of
the brain, causing raised intracranial pressure (116). It can be
induced by all acute or chronic brain insults. Cerebral edema is
closely associated with the development of secondary neuronal
damage, and may be an early marker for progressive neural injury
and neuronal cell death. The BBB disruption is the main cause
of vasogenic cerebral edema, which is often caused by arterial
hypertension, trauma, and tumor-induced release of vasoactive
and endothelial substances. The BBB disruption allows intravascu-
lar proteins and water to enter and accumulate in the parenchymal
extracellular space. Water in white matter can spread rapidly along
fiber tracts to the gray matter and other remote regions of the
brain, causing widespread cerebral swelling (117). Vasogenic cere-
bral edema is generally observed in acute brain insults (such as
TBI, stroke, chemical poisoning, and infections by pathogenic
microbes). Cytotoxic cerebral edema involves the intracellular
accumulation of excess water, usually because of dysfunctioning
sodium and potassium pumps in the neuronal cell membrane
(118). It is often caused by chemical toxins, immune response to
microbial infection, alcohol, illegal drugs, and damaged cells from
trauma or neurodegenerative diseases. Cerebral edema causes
many symptoms including headache, faintness, nausea, vomiting,
and blurred vision. In some severe cases, it can lead to seizures
and coma.
Inflammation
Inflammation is an immune response to harmful stimuli such
as injury, microbial invasion, damaged cells, or foreign materials.
Inflammation is a defense mechanism that protects the human
body from infection and injury, and initiates the tissue-healing
process. It leads to increased permeability of the vessels and an
increased number of plasma proteins and leukocytes immigrat-
ing through vessel walls to the injured tissues (119). Activation
of leukocytes results in the expression and release of classical
inflammatory mediators including cytokines, eicosanoids, and
complement, thus stimulating the signaling networks that regu-
late inflammatory responses to harmful stimuli (120). During the
inflammatory process, destruction and healing of the tissue can
happen simultaneously. If the inflammatory response is excessive
in the injured tissue, tissue destruction induced by leukocytes will
compromise the survival of the injured tissues or organs, causing
more severe insults than the initial harmful stimuli. Inflamma-
tory responses exist in almost all acute and chronic brain insults.
In contrast to other tissues, neuroinflammatory response in the
brain is induced and spread more rapidly because cellular infil-
tration in the brain in response to inflammation is weaker and
delayed (121). When the brain is injured by the initial insult, it will
activate microglial cells (the resident immune cells of the brain) to
produce pro-inflammatory cytokines (such as interleukins, inter-
ferons, and growth factors), leading to a prolonged or exaggerated
neuroinflammatory response in the injured areas of the brain
(122). The exaggerated neuroinflammatory response is critical
in the induction of progressive neural injury and neuronal cell
death, which causes more severe tissue destruction and neuronal
cell injury in the brain. Neuroinflammation has been recognized
to be involved in the development of subsequent neuropsychiatric
disorders following brain insults (123).
Cytotoxicity induced by neurotransmitter imbalance
Imbalances in some neurotransmitters (such as dopamine, 5-HT,
ACh, and glutamate) in the brain can cause stimulation or inhi-
bition of cell membrane receptors, leading to cytotoxicity. Cyto-
toxicity induces a variety of harmful effects in neurons, including
altered calcium influx, free radical damage,oxidative stress, inflam-
matory responses, and apoptosis, potentially leading to neuronal
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FIGURE 3 | Various acute and chronic brain insults cause post-injury
pathophysiological changes including cerebral edema, inflammation,
cytotoxicity, loss of cerebral blood flow autoregulation, and
apoptosis in the brain. These pathophysiological changes induce
secondary neuronal damage in the brain regions remote from the initial
injured site (the limbic system, basal ganglia system, brainstem, basal
forebrain, cerebellum, and cerebral cortex), leading to subsequent
neuropsychiatric disorders.
cell death and neurodegeneration (124). Cytotoxicity involves the
development of secondary neuronal damage triggered by many
types of brain insult such as TBI, stroke, brain tumors, neu-
rodegenerative diseases (Parkinson’s disease, Alzheimer’s disease,
ALS, HD), and poisoning with hazardous chemicals (OP pesti-
cides/chemical nerve agents, chemical neurotoxic substances, alco-
hol abuse, and drug abuse). Poisoning with hazardous chemicals
induces over-release of some neurotransmitters (ACh, dopamine,
5-HT, and/or glutamate) from neurons to produce prolonged
stimulation of post-synaptic neuron receptors, triggering exces-
sive calcium release and increased calcium influx in neuronal
cells (125). Increased calcium influx activates lipases, proteases,
kinases, phosphatases, and endonucleases in potentially harmful
metabolic cascades, thus arresting protein synthesis and depriv-
ing cells of enzymes or trophic factors essential to their survival
(126). In addition, intracellular calcium overload can result in free
radical-related damage and apoptosis by inducing excessive oxida-
tive stress and inflammatory responses. Altered calcium influx can
cause excitotoxic lesions in the affected neurons. Decreased release
of neurotransmitters contributes to some neurodegenerative dis-
eases such as Parkinson’s disease and Alzheimer’s disease. Greatly
decreased activity of dopamine-secreting cells caused by progres-
sive neuron death in the basal ganglia is the major cause of Parkin-
son’s disease (127). Reduced synthesis and activity of ACh in the
cholinergic neurons may involve the onset of Alzheimer’s disease
(128). Abnormal and decreased levels of glutamate transporters
have been observed in ALS and Alzheimer’s disease. Inhibition of
glutamate transporter causes elevated glutamate levels and alter-
ations in glutamate receptors, ultimately resulting in excitotoxic
lesion in neuronal cells (129).
Loss of cerebral blood flow autoregulation
Cerebral blood flow autoregulation is a process that maintains
adequate and stable cerebral blood flow and blood pressure to
the brain, and avoids underperfusion or overperfusion of the
brain. It plays an important role in both delivering sufficient
blood-containing oxygen and nutrients to the brain tissue for
cerebral metabolic need, and removing CO2 and other waste
products from the brain. The autoregulation of cerebral blood
flow is achieved primarily by dilation or contraction of cerebral
arterioles under the influence of multiple complex physiological
control systems (including carbon dioxide levels, cerebral meta-
bolic rate, neural activation, activity of the sympathetic nervous
system, posture, and other physiological variables) (130). Loss of
the ability to autoregulate and control cerebral blood flow in cere-
bral arterioles occurs often in acute brain insults (especially in TBI
and stroke), which results in massive cerebral edema, ischemia,
and hypoxia. Impairment of cerebral blood flow autoregulation
has been implicated in the development of secondary neuronal
damage (131).
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Apoptosis
In normal conditions, apoptosis generally confers benefits for the
human body during the life cycle. Apoptosis can help eliminate old
or dead cells by producing cell fragments (called apoptotic bod-
ies). Apoptotic bodies are easily engulfed and quickly removed
by phagocytic cells before they spill out onto surrounding cells
and cause damage (132). Under the condition that a brain insult
occurs, apoptosis becomes a programed cell death process that is
fundamental to immune responses and is detrimental to tissue,
which exacerbates brain damage and neurologic deficits (133).
The apoptosis program can be triggered by excessive free radical
formation, death-receptor (such as TNF and Fas receptors) liga-
tion, DNA damage, loss of mitochondrial function, and lysosomal
protease activation. Excessive apoptosis will result in uncontrolled
cell proliferation, differentiation, and transformation, which plays
a crucial role in triggering neuronal cell death (134, 135).
Apoptosis, characterized by blebbing, cell shrinkage, nuclear frag-
mentation, chromatin condensation, and chromosomal DNA
fragmentation, is a prominent feature in the brain after an insult
(136). Apoptotic processes have been implicated in almost all acute
and chronic brain insults, and may be the major contributor to
ultimate neuronal cell death/loss in many brain regions remote
from the initial injured site (e.g., the hippocampus, amygdale,
thalamus, the brainstem, basal ganglia system, the cerebellum, and
piriform cortex) (137, 138).
The pathophysiological changes associated with the initial brain
insults trigger secondary neuronal damage in the brain. Sec-
ondary neuronal damage is the delayed and progressive neuronal
cell death, neural loss, and axonal degeneration processes, which
occur in not only the initial injured site but also other brain
regions remote from the initial injured site. The mechanism by
which secondary neuronal damage can happen in other brain
regions remote from the initial injured site may involve multi-
ple pathophysiological reactions that occur globally throughout
the brain, including widespread cerebral edema and neuroin-
flammative responses, loss of cerebral blood flow autoregulation,
imbalances in neurotransmitters, defective neuronal signal trans-
duction, altered ionic balance, and apoptosis. Secondary neuronal
damage is the fundamental cause of subsequent neuropsychiatric
and neurological disorders following brain insult. Neuropsychi-
atric disorders could be the long-term prominent clinical manifes-
tations of the patients with brain insults, because chronic disability
following brain damage is mainly expressed as mental sequelae
rather than neurological deficits in humans (139). These chronic
neuropsychiatric disorders are serious public health problems that
result in the loss of many years of productive life and incur large
healthcare costs.
CONCLUSION
Neuropsychiatric disorders are commonly induced by both acute
(TBI, stroke, chemical poisoning, and infections by pathogenic
microbes) and chronic (brain tumors, alcohol abuse, drug abuse,
and neurodegenerative diseases) brain insults. Clinical manifesta-
tions of neuropsychiatric disorders may vary among the patients
with different types of brain insult, depending on the cause, type,
and severity of injury, acute or chronic condition, and the brain
regions affected, as well as on the age and health status of the
patient. However, 40% of neuropsychiatric signs and symptoms
were found to be commonly shared by traumatic, infectious, toxic,
oncogenic, and degenerative brain insults, suggesting that the same
or similar brain regions/structures can be possibly affected by
different acute and chronic brain insults.
The histomorphological basis for neuropsychiatric disorders
might be the progressive neuronal cell death and neural injury
in the brain regions that control memory, consciousness, sleep,
and cognitive, emotional, somatic, psychomotor, and neuromotor
functions, such as the limbic system, basal ganglia system, brain-
stem, basal forebrain, cerebellum, and cerebral cortex. Because
most of the brain regions affected are far away from the ini-
tial injured site, the histomorphological alterations in the remote
brain regions may mainly result from secondary neuronal dam-
age triggered by the initial insult. Secondary neuronal damage
may be largely responsible for subsequent neuropsychiatric disor-
ders following various brain insults. However, it should be noted
that clinical manifestations of neurological disorders may tend
to be similar even when the histomorphological alterations in
the brain region affected are dissimilar, because the brain has
only a few common pathophysiological responses (such as cere-
bral edema, inflammation, cytotoxicity, loss of cerebral blood flow
autoregulation, and the apoptos) to injuries.
If a patient has neuropsychiatric signs and symptoms of
unknown origin, physicians and psychiatrists should be aware
that potential neuronal damage can possibly exist in the patient’s
brain and not simply conclude that the patient has a psychological
problem associated with social/environmental factors. Necessary
treatment aimed at slowing down the process of neuronal damage
and attenuating individual symptoms or clusters of neuropsy-
chiatric and neurological disorders may help improve recovery
of neurobehavioral functions. The clinical symptom-comparing
approach used in the present study to identify the same clin-
ical manifestations may be a useful tool for investigating the
causes of neuropsychiatric disorders and other complex diseases
of unknown origin.
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